On the recordMarch 22, 2023
We pointed to the risk of higher launch prices and distorted pricing practices based on projections validated by the nonpartisan Congressional Budget Office.
Source
congress.govWe pointed to the risk of higher launch prices and distorted pricing practices based on projections validated by the nonpartisan Congressional Budget Office.
Wyden warns about the negative impact of price controls on drug pricing.
Share & report
More from Ron Wyden
Paramount just paid Trump a bribe for merger approval. When Democrats retake power, I’ll be first in line calling for federal charges.
Colleagues, this amendment offered by Senator Hawley and myself says that $880 billion in Medicaid cuts have no place in this resolution. Right now, those cuts can be found on page 46, lines 3 through 7, and we ought to get rid of them…